PE20.01 The Impact of Progestin-based Contraceptive Initiation on the Cervicovaginal Proteome in participants from the ECHO trialE-posterMicrobiome & STI: impact on prevention
PE20.02 The effect of HPV-associated anal dysplasia on HIV susceptibility in men who have sex with menE-posterMicrobiome & STI: impact on prevention
PU19.01 The impact of vaginal Lactobacillus isolates on host gene expression involved in inflammation in the female genital tractPublication OnlyMicrobiome & STI: impact on prevention
PE18.01 Estimating the impact of PrEP regimens containing long-acting injectable cabotegravir or daily oral tenofovir/emtricitabine among men who have sex with men in the United States: mathematical modelling for HPTN 083E-posterMathematical modelling: impact and effectiveness
PE18.02 Predicting PrEP efficacy in women with partial adherence to tenofovir disoproxil fumarate/emtricitabineE-posterMathematical modelling: impact and effectiveness
PU18.01 Simple tool for geographic prioritization of PrEP for adolescent girls and young women based on cost-effectivenessPublication OnlyMathematical modelling: impact and effectiveness
PU18.02LB Modeling the probability of HIV infection and its reduction by microbicides using deterministic mass transport theory coupled to viral dynamicsPublication OnlyMathematical modelling: impact and effectiveness
OA05.01 Role of HLA-E antigen presentation on NK control of HIV infection Oral Abstract SessionInnate and trained immunity
OA05.02 Acute SIV Induces BHLH gene variants prior to adaptive natural killer cell formationOral Abstract SessionInnate and trained immunity
OA14.03 Analysis of the early responses to HIV-1 in matched treatment naïve individuals reveals early soluble proteins that are associated with in vivo virus controlOral Abstract SessionInnate and trained immunity
seek-warrow-warrow-eseek-e121 - 130 of 444 items